| Bioactivity | MTSEA hydrobromide is a sulfhydryl-reactive compound that modifies free cysteine residues to produce a positively charged side chain approximately the size of lysine[1]. |
| Invitro | Cys modification by MTSEA reduces susceptibility to Cd activation of receptors with A8C or L10C substitutions[1]. |
| Name | MTSEA hydrobromide |
| CAS | 16599-33-0 |
| Formula | C3H10BrNO2S2 |
| Molar Mass | 236.15 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wilding TJ, et al. Cadmium opens GluK2 kainate receptors with cysteine substitutions at the M3 helix bundle crossing. J Gen Physiol. 2019 Apr 1;151(4):435-451. |
MTSEA hydrobromide
CAS: 16599-33-0 F: C3H10BrNO2S2 W: 236.15
MTSEA hydrobromide is a sulfhydryl-reactive compound that modifies free cysteine residues to produce a positively charge
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.